Validation study for rapid profiling of immunohistochemical markers for breast cancer
Not Applicable
- Conditions
- Cancer
- Registration Number
- PACTR202111860919273
- Lead Sponsor
- Aikili Biosystems Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Adult female patients with known or suspected breast malignancy being referred for biopsy of the suspicious lesion.
Women with metastatic breast cancer and who will undergo treatment in the subsequent 2 weeks for recurrent disease with either cytotoxic and/or targeted therapies.
Women with metastatic breast cancer with any prior chemotherapy regimen or never treated allowed.
Women with metastatic breast cancer who must be able to understand and sign an informed consent.
Exclusion Criteria
Children defined as patients under 18 years of age
Patients not pursuing cancer treatment / monitoring at Aga Khan University Hospital
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method